Posts tagged Pharmaceutucal.
Blogs
3 minute read
On March 26, 2012, the U.S. Department of Health & Human Services Office of Inspector General (the “OIG”) published a report summarizing a February 23, 2012roundtable meeting between the OIG and compliance professionals from twenty-three pharmaceutical manufacturers. The compliance officers and other professionals attending the meeting all represented companies currently operating under Corporate Integrity Agreements (or “CIAs”). CIAs are generally negotiated between a company and the government in connection with settling various types of federal ...
Blog Editors
Recent Updates
- Fighting Fire with Fire: Project Glasswing and AI-Powered Cyber Defense in Health Care, Financial Health and Other Critical Infrastructure
- Microsoft Copilot Health: Another Player In AI-Driven Healthcare
- The Proposed HHS Budget for 2027: Key Takeaways
- Contractor to Pay More Than $17 Million in First DOJ False Claims Act Settlement Alleging Illegal DEI
- Listen: DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care